Surrey Memorial Hospital is a publicly funded hospital owned and operated by Fraser Health in the city of Surrey, British Columbia, Canada adjacent to King George Boulevard. SMH is located on the unceded and traditional shared territories of the Katzie, Semiahmoo, Kwantlen, Kwikwetlem and Tsawwassen First Nations.

There are 650 beds in Surrey Memorial Hospital.

During the past decade, Surrey Memorial Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 3 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Surrey Memorial Hospital" #1 sponsor was "University of British Columbia" with 12 trials, followed by "Fraser Health" with 3 trials sponsored, "Active Biotech AB" with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Surrey Memorial Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 11 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Heart and Stroke Foundation of Canada" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "Ottawa Hospital Research Institute" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Surrey Memorial Hospital" are "Myocardial Infarction" (3 trials), "Cerebrovascular Accident" (2 trials), "Critical Illness" (2 trials), "Stroke" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Surrey Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Surrey Memorial Hospital" are "Drug" (14 trials), "Other" (6 trials), "Behavioral" (5 trials), "Procedure" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "ABR-215050, tasquinimod" (1 trials), "ARB + DMX-200" (1 trials), "ARBs and/or ACE inhibitors" (1 trials) and "Alair System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Surrey Memorial Hospital" are 29 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Surrey Memorial Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Surrey Memorial Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Surrey Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".